Citation: J. Bernardini et al., PATIENT SURVIVAL WITH RENAL REPLACEMENT THERAPY IN HEART-TRANSPLANTATION PATIENTS, ASAIO journal, 44(5), 1998, pp. 546-548
Authors:
GOKAL R
ALEXANDER S
ASH S
CHEN TW
DANIELSON A
HOLMES C
JOFFE P
MONCRIEF J
NICHOLS K
PIRAINO B
PROWANT B
SLINGENEYER A
STEGMAYR B
TWARDOWSKI Z
VAS S
Citation: R. Gokal et al., PERITONEAL CATHETERS AND EXIT-SITE PRACTICES TOWARD OPTIMUM PERITONEAL ACCESS - 1998 UPDATE (OFFICIAL REPORT FROM THE INTERNATIONAL SOCIETYFOR PERITONEAL-DIALYSIS), Peritoneal dialysis international, 18(1), 1998, pp. 11-33
Citation: S. Hussain et B. Piraino, PERITONITIS ASSOCIATED WITH MASSIVE PNEUMOPERITONEUM FROM FAILURE TO FLUSH, Peritoneal dialysis international, 18(1), 1998, pp. 80-82
Authors:
JONES M
HAGEN T
BOYLE CA
VONESH E
HAMBURGER R
CHARYTAN C
SANDRONI S
BERNARD D
PIRAINO B
SCHREIBER M
GEHR T
FEIN P
FRIEDLANDER M
BURKART J
ROSS D
ZIMMERMAN S
SWARTZ R
KNIGHT T
KRAUS A
MCDONALD L
HARTNETT M
WEAVER M
MARTIS L
MORAN J
Citation: M. Jones et al., TREATMENT OF MALNUTRITION WITH 1.1-PERCENT AMINO-ACID PERITONEAL-DIALYSIS SOLUTION - RESULTS OF A MULTICENTER OUTPATIENT STUDY, American journal of kidney diseases, 32(5), 1998, pp. 761-769
Citation: J. Bernardini et B. Piraino, COMPLIANCE IN CAPD AND CCPD PATIENTS AS MEASURED BY SUPPLY INVENTORIES DURING HOME VISITS, American journal of kidney diseases, 31(1), 1998, pp. 101-107
Authors:
TZAMALOUKAS AH
MURATA GH
PIRAINO B
RAO P
BERNARDINI J
MALHOTRA D
OREOPOULOS DG
Citation: Ah. Tzamaloukas et al., PERITONEAL UREA AND CREATININE CLEARANCES IN CONTINUOUS PERITONEAL-DIALYSIS PATIENTS WITH DIFFERENT TYPES OF PERITONEAL SOLUTE TRANSPORT, Kidney international, 53(5), 1998, pp. 1405-1411
Authors:
JONES M
GEHR T
BURKART J
HAMBURGER R
KRAUS A
PIRAINO B
HAGEN T
OGRINC F
WOLFSON M
Citation: M. Jones et al., USE OF A 1.1-PERCENT AMINO-ACID PERITONEAL-DIALYSIS SOLUTION TO OFFSET AMINO-ACID (AA) AND PROTEIN LOSSES, Journal of the American Society of Nephrology, 8, 1997, pp. 1219-1219
Authors:
TZAMALOUKAS AH
MURATA GH
PIRAINO B
RAO P
MALHOTRA D
BERNARDINI J
OREOPOULOS DG
Citation: Ah. Tzamaloukas et al., COMPARATIVE EFFECT OF PERITONEAL TRANSPORT TYPE OF PERITONEAL UREA AND CREATININE CLEARANCE IN CAPD, Journal of the American Society of Nephrology, 8, 1997, pp. 1343-1343
Authors:
TZAMALOUKAS AH
MURATA GH
PIRAINO B
RAO P
BERNARDINI J
OREOPOULOS DG
MALHOTRA D
Citation: Ah. Tzamaloukas et al., PREDICTION OF ADEQUACY OF KT V-UREA IN CAPD FROM URINE AND DRAIN VOLUMES/, Journal of the American Society of Nephrology, 8, 1997, pp. 1344-1344
Citation: J. Bernardini et B. Piraino, MEASURING COMPLIANCE WITH PRESCRIBED EXCHANGES IN CAPD AND CCPD PATIENTS, Peritoneal dialysis international, 17(4), 1997, pp. 338-342
Authors:
TZAMALOUKAS AH
MURATA GH
PIRAINO B
RAO P
MALHOTRA D
BERNANDINI J
VOUDIKLARI S
BALASKAS EV
NICOLOPOULOU N
DIMITRIADIS A
DOMBROS NV
OREOPOULOS DG
Citation: Ah. Tzamaloukas et al., STATISTICAL-MODEL OF PERITONEAL KT V IN CAPD, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1391-1391
Authors:
FRIED LF
BERNARDINI J
JOHNSTON JR
PIRAINO B
Citation: Lf. Fried et al., PERITONITIS INFLUENCES MORTALITY IN PERITONEAL-DIALYSIS PATIENTS, Journal of the American Society of Nephrology, 7(10), 1996, pp. 2176-2182
Citation: B. Piraino, IS IT POSSIBLE TO DECREASE THE RATE OF STAPHYLOCOCCUS-AUREUS PERITONITIS, Peritoneal dialysis international, 16(5), 1996, pp. 446-447
Citation: L. Fried et al., NEITHER SIZE NOR WEIGHT PREDICTS SURVIVAL IN PERITONEAL-DIALYSIS PATIENTS, Peritoneal dialysis international, 16(4), 1996, pp. 357-361
Citation: An. Khan et al., LOW SEROCONVERSION WITH HEPATITIS-B VACCINATION IN PERITONEAL-DIALYSIS PATIENTS, Peritoneal dialysis international, 16(4), 1996, pp. 370-373
Citation: B. Piraino, COMPARISONS OF THE SWAN NECK AND TENCKHOFF CATHETERS - RESPONSE TO TWARDOWSKI ET-AL, Peritoneal dialysis international, 16(2), 1996, pp. 191-192
Authors:
BERNARDINI J
PIRAINO B
HOLLEY J
JOHNSTON JR
LUTES R
Citation: J. Bernardini et al., A RANDOMIZED TRIAL OF STAPHYLOCOCCUS-AUREUS PROPHYLAXIS IN PERITONEAL-DIALYSIS PATIENTS - MUPIROCIN CALCIUM OINTMENT 2-PERCENT APPLIED TO THE EXIT SITE VERSUS CYCLIC ORAL RIFAMPIN, American journal of kidney diseases, 27(5), 1996, pp. 695-700